Altx Therapeutics Limited
16677457
Some Concerns
- Current liabilities exceed current assets (-10)
- Going concern doubt noted in accounts (-10)
Details
Compliance
Last accounts
31/03/2026
small
Next accounts due
31/12/2027
Confirmation statement
Last:
Due 10/09/2026
Industry
Officers
director · Since 28/08/2025
DIRECTOR
BRITISH,CHILEAN · ENGLAND · Age 37
Also on 3 other boards
director · Since 28/08/2025
MANAGING PARTNER
BRITISH · UNITED KINGDOM · Age 63
Also on 3 other boards
Persons with Significant Control
Slingshot Therapeutics Holdings Limited
Burnham House, Splash Lane, Wyton, Huntingdon, PE28 2AF
Reg: 15871470 · Companies House · Private Limited Company
Notified 04/11/2025
Former PSCs
Slingshot Therapeutics Holdings Limited
Ceased 20/10/2025
Dr Simon Boulton
Ceased 04/11/2025
CompanyRankvs 1491+ SIC 72110 peers43
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Going concern doubt: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Going Concern Doubt
of the second funding tranche represents a material uncertainty related to events or conditions that may cast significant doubt on the company's ability to continue as a going concern. ALTX THERAPEUTICS LIMITED NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE PERIOD ENDED 31 MARCH 2026 1 Accounting policies (Continued) - 3 - 1.3 Significant judgements and estimations In the a
Key FinancialsYear ending 31/03/2026
Net Worth
£70
Balance sheet strength
Cash
£3.6M
Cash in the bank
Net Current Assets
£3.1M
Working capital
Current Assets
£3.8M
Current Liabilities
£757k
Fixed Assets
£860
Debtors
£204k
Balance Sheet
EstimatesDerived
| Year | Current Ratio |
|---|---|
| 2026 | 5.07 |
Derived from filed accounts. Not audited figures.